E-LIB Suche - Ergebnisse für: van Veelen, Ard J.

1

Exploring the impact of patient‐specific clinical features ..:

van Veelen, Ard ; Veerman, G. D. Marijn ; Verschueren, Marjon V....
International Journal of Cancer. 154 (2023) 2 - p. 332-342 , 2023

Link: https://doi.org/10.1002/..

2

Development and validation of an HPLC–MS/MS method to simul..:

Gulikers, Judith L. ; van Veelen, Ard J. ; Sinkiewicz, Elishia M. J....
Biomedical Chromatography. 37 (2023) 6 - p. , 2023

Link: https://doi.org/10.1002/..

3

Durvalumab after Chemoradiotherapy in Patients with Stage I..:

Verschueren, Marjon V ; Dijs, Talitha ; Gulikers, Judith L...
Immunotherapy. 15 (2023) 11 - p. 839-851 , 2023

Link: https://doi.org/10.2217/..

4

Incidence of Bone Metastases and Skeletal-Related Events in..:

Brouns, Anita J.W. M. ; van Veelen, Ard ; Veerman, G. D. Marijn...
JTO Clinical and Research Reports. 4 (2023) 5 - p. 100513 , 2023

Link: https://doi.org/10.1016/..

5

Pharmacokinetic boosting of osimertinib with cobicistat in ..:

van Veelen, Ard ; Gulikers, Judith ; Hendriks, Lizza E.L....
Lung Cancer. 171 (2022) - p. 97-102 , 2022

Link: https://doi.org/10.1016/..

6

Characteristics of patients with lung cancer in clinical pr..:

van Veelen, Ard ; Abtahi, Shahab ; Souverein, Patrick...
Cancer Epidemiology. 78 (2022) - p. 102149 , 2022

Link: https://doi.org/10.1016/..

7

Development and validation of an HPLC–MS/MS method to simul..:

van Veelen, Ard ; van Geel, Robin ; Schoufs, Roy...
Biomedical Chromatography. 35 (2021) 12 - p. , 2021

Link: https://doi.org/10.1002/..

8

Comment on "Hydrochlorothiazide use and risk of nonmelanoma..:

van Veelen, Ard ; Nielen, Johannes T.H. ; van Geel, Robin.
Journal of the American Academy of Dermatology. 85 (2021) 6 - p. e357 , 2021

Link: https://doi.org/10.1016/..

9

Validation of an analytical method using HPLC–MS/MS to quan..:

van Veelen, Ard ; van Geel, Robin ; de Beer, Yvo...
Biomedical Chromatography. 34 (2020) 4 - p. , 2020

Link: https://doi.org/10.1002/..

10

Impact of Average Daily and Cumulative Dose of Statins on M..:

Abtahi, Shahab ; Oshagbemi, Olorunfemi A. ; van Veelen, Ard
The American Journal of Medicine. 132 (2019) 7 - p. e621 , 2019

Link: https://doi.org/10.1016/..

11

Using Real-World Data in Health Technology Assessment (HTA)..:

Makady, Amr ; van Veelen, Ard ; Jonsson, Páll...
PharmacoEconomics. 36 (2017) 3 - p. 359-368 , 2017

Link: https://doi.org/10.1007/..

12

OP93 Conditional Financing In Health Technology Assessment ..:

Makady, Amr ; Nijmeijer, Hugo ; van Veelen, Ard...
International Journal of Technology Assessment in Health Care. 33 (2017) S1 - p. 42-43 , 2017

Link: https://doi.org/10.1017/..

13

VP08 Real-World Data Use In Health Technology Assessments: ..:

Makady, Amr ; van Veelen, Ard ; de Boer, Anthonius...
International Journal of Technology Assessment in Health Care. 33 (2017) S1 - p. 149-150 , 2017

Link: https://doi.org/10.1017/..

14

Exploring the impact of patient-specific clinical features ..:

van Veelen, Ard ; Veerman, G. D.Marijn ; Verschueren, Marjon V...
0020-7136. , 2024

Link: https://dspace.library.u..

15

Exploring the impact of patient-specific clinical features ..:

van Veelen, Ard ; Veerman, G. D.Marijn ; Verschueren, Marjon V...
https://pure.eur.nl/en/publications/3c6b1705-6fac-44d8-a1cf-f53289489218. , 2024

Link: https://pure.eur.nl/en/p..